These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 32894243)
1. Microglia Demonstrate Local Mixed Inflammation and a Defined Morphological Shift in an APP/PS1 Mouse Model. Holloway OG; King AE; Ziebell JM J Alzheimers Dis; 2020; 77(4):1765-1781. PubMed ID: 32894243 [TBL] [Abstract][Full Text] [Related]
2. Long-term running exercise improves cognitive function and promotes microglial glucose metabolism and morphological plasticity in the hippocampus of APP/PS1 mice. Zhang SS; Zhu L; Peng Y; Zhang L; Chao FL; Jiang L; Xiao Q; Liang X; Tang J; Yang H; He Q; Guo YJ; Zhou CN; Tang Y J Neuroinflammation; 2022 Feb; 19(1):34. PubMed ID: 35123512 [TBL] [Abstract][Full Text] [Related]
3. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037 [TBL] [Abstract][Full Text] [Related]
4. Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling. Li L; Wu XH; Zhao XJ; Xu L; Pan CL; Zhang ZY J Neuroinflammation; 2020 Feb; 17(1):61. PubMed ID: 32066466 [TBL] [Abstract][Full Text] [Related]
5. Late-life environmental enrichment preserves short-term memory and may attenuate microglia in male APP/PS1 mice. Stuart KE; King AE; King NE; Collins JM; Vickers JC; Ziebell JM Neuroscience; 2019 Jun; 408():282-292. PubMed ID: 30999032 [TBL] [Abstract][Full Text] [Related]
6. Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model. Park TS; Ryu YK; Park HY; Kim JY; Go J; Noh JR; Kim YH; Hwang JH; Choi DH; Oh WK; Lee CH; Kim KS Int J Mol Med; 2017 Jan; 39(1):21-30. PubMed ID: 28004107 [TBL] [Abstract][Full Text] [Related]
7. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice. McIntosh A; Mela V; Harty C; Minogue AM; Costello DA; Kerskens C; Lynch MA Brain Pathol; 2019 Sep; 29(5):606-621. PubMed ID: 30661261 [TBL] [Abstract][Full Text] [Related]
8. Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice. Unger MS; Schernthaner P; Marschallinger J; Mrowetz H; Aigner L J Neuroinflammation; 2018 Sep; 15(1):274. PubMed ID: 30241479 [TBL] [Abstract][Full Text] [Related]
9. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice. Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390 [TBL] [Abstract][Full Text] [Related]
10. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance. Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458 [TBL] [Abstract][Full Text] [Related]
11. Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation. Zhou J; Yu W; Zhang M; Tian X; Li Y; Lü Y Neurochem Res; 2019 May; 44(5):1138-1151. PubMed ID: 30756214 [TBL] [Abstract][Full Text] [Related]
12. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model. Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764 [TBL] [Abstract][Full Text] [Related]
14. Characterization of astrocytes throughout life in wildtype and APP/PS1 mice after early-life stress exposure. Abbink MR; Kotah JM; Hoeijmakers L; Mak A; Yvon-Durocher G; van der Gaag B; Lucassen PJ; Korosi A J Neuroinflammation; 2020 Mar; 17(1):91. PubMed ID: 32197653 [TBL] [Abstract][Full Text] [Related]
19. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept. Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333 [TBL] [Abstract][Full Text] [Related]
20. Determination of spatial and temporal distribution of microglia by 230nm-high-resolution, high-throughput automated analysis reveals different amyloid plaque populations in an APP/PS1 mouse model of Alzheimer's disease. Scheffler K; Stenzel J; Krohn M; Lange C; Hofrichter J; Schumacher T; Brüning T; Plath AS; Walker L; Pahnke J Curr Alzheimer Res; 2011 Nov; 8(7):781-8. PubMed ID: 21244350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]